This move is archived. Current quotes and coverage live on the stock page.
Get LABS alerts:
Medipharm Labs Corp has seen a significant surge in its stock price, closing up 7.69% in the last trading session.
On the TSX, Medipharm Labs Corp (LABS.TO) experienced a notable uptick in its stock performance, with shares closing at CA$0.07 after a 7.69% increase. This rise comes amidst growing interest in the medical cannabis sector, especially as the company expands its international presence and capitalizes on new opportunities.
Advertisement
Medipharm Labs Corp
LABS.TO
LABS.TO
Medipharm Labs Corp
WealthAwesomeMarket cap
$32.04M
52W high
$0.10
52W low
$0.06
1W change
+0.00%
Beta
0.93
Analyst Price Targets
Based on analyst covering LABS · as of Sep 17, 2026
Wall Street analysts forecast LABS stock price to rise 33.3% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.10
+33.3% Upside
Current Price
C$0.07
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on LABS's historical volatility
30-Day Vol
61.9%
Annualized
90-Day Vol
75.2%
Annualized
Trend (90d)
+0.0%
Annualized drift
90d Mean
C$0.07
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.07 | C$0.06 – C$0.09 |
| 60 trading days | C$0.07 | C$0.05 – C$0.09 |
| 90 trading days | C$0.07 | C$0.05 – C$0.10 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Keep an eye on Medipharm Labs Corp as it builds momentum, particularly with its recent expansions and positive revenue trends in the international market.
Medipharm Labs Corp Closes Up 7.69% in Last Session
With a market cap of CA$27.6 million, Medipharm Labs is navigating a challenging market but is showing signs of resilience and growth.
Bull case
The company’s recent financial results indicate strong growth, with international medical cannabis revenue increasing significantly. This positions Medipharm Labs to attract more investment and market interest.
Bear case
Despite the positive movement, Medipharm Labs still operates at a loss, which could deter risk-averse investors. Ongoing financial instability may impact its long-term growth potential.
Advertisement
Recent Performance and Market Sentiment
Medipharm Labs Corp's stock has seen a remarkable increase of 7.69% in the last trading session, closing at CA$0.07. This uptick reflects growing investor confidence in the company, especially as it reports strong revenue growth in international markets. The positive sentiment is supported by the company's strategic efforts to expand its operations and seize new market opportunities.
Growth Potential in the Medical Cannabis Sector
The medical cannabis sector is experiencing significant growth, and Medipharm Labs is well-positioned to benefit from this trend. With international medical cannabis revenue growing by 43% year-over-year, the company is expanding its reach and capabilities. Investors are encouraged to monitor developments closely as Medipharm Labs continues to establish itself in a competitive landscape.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
